The self-insured part of the employer market is more likely to cover GLP-1s, since employers may feel pressure to cover the medications, and because the tenure of workers is generally longer in larger self-insured companies
More serious but rare risks can include pancreatitis, gallbladder issues, and thyroid C-cell tumors (in animal studies)
Randomized noninferiority trial comparing 2 commercial intramammary antibiotics for the treatment of nonsevere clinical mastitis in dairy cows
doi:10.1515/bchm2.1932.210.1-2.33
However, most previous NMA studies have compared specific drugs (e.g., pioglitazone and rosiglitazone) or combinations of drug regimens (e.g., rosiglitazone+losartan, rosiglitazone+ metformin) rather than drug classes [38,39,42]